Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
BenevolentAI (United Kingdom) · Imperial College London
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,487
total citations
- FWCI
- 34.41
- Percentile
- 100%
- References
- 13
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Lung
- Virology
- Medicine
- Virus
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus
- Coronavirus disease 2019 (COVID-19)
- Computational biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.